POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No64/2019
Date of issue:2019-11-14
Short name of the issuer
SOPHARMA AD
Subject
Sopharma AD is among the largest investors in Moldova
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Sopharma AD notifies that on 12 November, with the participation of His Excellency Evgueni Stoytchev, the Ambassador of the Republic of Bulgaria in Moldova, Sopharma AD celebrated the opening of a new warehouse and administrative building in Kishinev with a total area of 5000 sq. m. The warehouse will provide 75 new working places and will support the distribution activities of pharmaceutical and other health related products of Sopharma AD in Moldova, further the centralization will lead to improved efficiency and optimization of the processes. Following its intentions to grow in Moldova, Sopharma AD purchased 29% of the capital of RAP Pharma International and reached 80% ownership in the company. RAP Pharma International also has a new Executive director Mr. Victor Tomsha – a young specialist with economic education and professional experience in large European companies.
Annexes
FileDescription
3JR_2019_Moldova_espi.pdfSopharma AD is among the largest investors in Moldova
SOPHARMA AD
(fullname of the issuer)
SOPHARMA ADFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification of the WSE in Warsow)
1220Sofia
(post code)(city)
IlienskoShosse16
(street)(number)
+359 2 813 42 00+359 2 936 02 86
(phone number)(fax)
(e-mail)(web site)
nd
(NIP)(REGON)
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2019-11-14Ognian Donev Executive director
3JR_2019_Moldova_espi.pdf